Jiang and colleagues described that endogenous expression levels of WNT3 in hESCs was a biomarker capable of predicting which hPSC lines were most amenable to endoderm differentiation 44
A 2022 systematic review in Obesity Reviews found that GLP-1 associated weight loss showed comparable or slightly better muscle preservation than diet-only approaches
Studies indicate that increased dietary fibre intake can improve post-meal glucose responses and may increase GLP-1 secretion
Systemic chronic low-grade inflammation and localized renal inflammatory injury play pivotal roles in the pathogenesis of obesity-related glomerulopathy (ORG), with the TXNIP/NLRP3 pathway serving as a key mediator in activating inflammatory cascades [5]
The GLP-1 agonist market is expanding quickly and this studys results indicate there may eventually be another oral GLP-1 agonist on the market if the phase 3 trial is successful and if the manufacturer seeks FDA approval, added Marilyn Tan, MD, an endocrinologist and professor of medicine at Stanford University
Such studies are especially challenging for aging, which isnt recognized as a treatable condition by health authorities and is difficult to study over time